Partner Headlines - LLY

  1. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD
  2. Screening Pharma Stocks Amid Turnaround

    YCharts
  3. Sarah Ketterer Dives in when Others Pull Out

    GuruFocus
  4. Credit Suisse Raises Eli Lilly Price Target

    Benzinga
  5. Veeva Systems Flies High On Cloud For Life Sciences

    IBD
  6. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD
  7. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD
  8. US Stock Futures Rise Ahead Of Earnings, Economic Data

    Benzinga
  9. Earnings Scheduled For October 23, 2014

    Benzinga
  10. CANDA NK-2 Files Motion To Dismiss Patent Infringement Suit

    Benzinga
  11. Lilly, Zymeworks Announce Expansion Of Strategic Licensing And ...

    Benzinga
  12. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga
  13. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD
  14. UPDATE: Lilly To Initiate Efforts To Sell Guayama Site

    Benzinga
  15. Lilly Announces Plan to Realign Puerto Rico Manufacturing Operations

    Benzinga
  16. Drug Analysts Mull End Of 'Double Irish' Loophole

    IBD
  17. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts
  18. Meet 5 Top International Stocks Not Based In China

    IBD
  19. Dyax Offers Highlights of Recent Progress in Licensing, Funded-Research ...

    Benzinga
  20. Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone

    Benzinga
  21. Drug giants target Alzheimer's

    IBD
  22. What Is A High Risk Market?

    Benzinga
  23. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt ...

    GuruFocus
  24. Markets Little Changed In Low Volume And Slow News Ahead Of Long ...

    Benzinga
  25. Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey

    Benzinga
  26. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers ...

    Benzinga
  27. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now ...

    Benzinga
  28. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga
  29. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  30. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical ...

    Benzinga
  31. Thursday Morning Earnings Reports

    Benzinga
  32. Earnings Scheduled For July 24, 2014

    Benzinga
  33. New Study Shows Beta-Amyloid Imaging Is Associated With Altered ...

    Benzinga
  34. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover ...

    Benzinga
  35. Benzinga's Top #PreMarket Gainers

    Benzinga
  36. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  37. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  38. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga
  39. Benzinga's Top Upgrades

    Benzinga
  40. Eli Lilly is on the Right Track

    GuruFocus
  41. Celgene Sees Better Results For Psoriatic Arthritis

    IBD
  42. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  43. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  44. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  45. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  46. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  47. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent ...

    Benzinga
  48. Eli Lilly insulin trial succeeds

    IBD
  49. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  50. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  51. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  52. UPDATE: Eli Lilly Announces Peglispro Shows Superiority Compared ...

    Benzinga
  53. Can Pfizer Make Up Its Loss?

    GuruFocus
  54. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  55. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  56. Will Pfizer's Q1 2014 Earnings Beat the Street on May 5, 2014?

    GuruFocus
  57. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  58. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  59. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  60. Vanguard Health Care Fund's Top Quarterly Holdings

    GuruFocus
  61. Actavis Earns Over-The-Top Q1

    IBD
  62. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  63. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD
  64. China Rule Change Further Opens Yuan To World Markets

    IBD
  65. These Three Pharmaceutical Companies Shake The Market With Their ...

    GuruFocus
  66. Drugmakers' Q1 was anemic

    IBD
  67. Eli Lilly Jr. Made His Firm A Pharmaceutical Power

    IBD
  68. Earnings Scheduled For April 24, 2014

    Benzinga
  69. Big Pharmas Swap Specialties

    IBD
  70. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  71. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  72. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  73. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  74. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  75. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  76. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  77. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  78. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  79. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  80. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  81. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  82. ELI LILLY

    IBD
  83. No Legwork Mondays – Takeda, Eli Lilly, And Actos

    Benzinga
  84. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  85. Lilly, Takeda must pay $9 bil

    IBD
  86. Ethical Drug Stocks Are Struggling

    IBD
  87. UPDATE: BMO Capital Upgrades Eli Lilly

    Benzinga
  88. Takeda, Lilly to 'Vigorously Challenge' Actos Ruling

    FoxBusiness
  89. Benzinga's Top Upgrades

    Benzinga
  90. Takeda Responds to $6B Verdict in Diabetes Drug Case

    Benzinga
  91. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  92. Pfizer Breast-Cancer Drug Scores, But Street Cautious

    IBD
  93. Market Wrap For April 3: Markets Winning Streak Fails To Extend ...

    Benzinga
  94. Wide Moat Stocks: Protection In A Correction

    YCharts
  95. UPDATE: Cowen & Company Upgrades Eli Lilly

    Benzinga
  96. Benzinga's Top Upgrades

    Benzinga
  97. Biotech Auxilium Boosts Position In Men's Health Care

    IBD
  98. Lilly Expands Generic Deal With Prasco

    FoxBusiness
  99. UPDATE: Bank of America Reiterates on Eli Lilly and Co. Following ...

    Benzinga
  100. Merck Snags Baxter Executive As CFO

    FoxBusiness
Trading Center